This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Acute Kidney Injury, Subject name: Medicine
Monoclonal antibodies to the CD25 (IL-2a) receptors are used for a treatment of: 
Select and explain. 
A. Hematological neoplasm, B. Autoimmune disease, C. Bone marrow transplantation, D. Kidney transplant rejection
D: Kidney transplant rejection
Answer: D: Kidney transplant rejection 
Explanation: (Antibodies to CD 25) -Basiliximab reduces the incidence and severity of acute rejection in kidney transplantation without increasing the incidence of oppounistic infections.